OBJECTIVE: Despite a lack of data demonstrating benefit, psychotropic medications are frequently prescribed for patients with anorexia nervosa. METHOD: We studied 525 women (18-54 years of age) with anorexia nervosa who presented to the Clinical Research Center at the Massachusetts General Hospital between January 1997 and December 2009. For this analysis, participants were a priori divided into two groups based on date of presentation (Group I: participants presenting between 1997 and 2002; Group II: participants presenting between 2003 and 2009). RESULTS: Overall, 53% of participants reported current use of any psychotropic medication; 48.4% reported use of an antidepressant and 13% reported use of an antipsychotic. Twice as many participants in Group II (18.5%) reported using atypical antipsychotics as compared to Group I (8.9%) (p = 0.002). DISCUSSION: A majority of participants with anorexia nervosa report using psychotropic medications despite lack of data supporting their efficacy. These data are concerning given the known adverse effects of these medications.
OBJECTIVE: Despite a lack of data demonstrating benefit, psychotropic medications are frequently prescribed for patients with anorexia nervosa. METHOD: We studied 525 women (18-54 years of age) with anorexia nervosa who presented to the Clinical Research Center at the Massachusetts General Hospital between January 1997 and December 2009. For this analysis, participants were a priori divided into two groups based on date of presentation (Group I: participants presenting between 1997 and 2002; Group II: participants presenting between 2003 and 2009). RESULTS: Overall, 53% of participants reported current use of any psychotropic medication; 48.4% reported use of an antidepressant and 13% reported use of an antipsychotic. Twice as many participants in Group II (18.5%) reported using atypical antipsychotics as compared to Group I (8.9%) (p = 0.002). DISCUSSION: A majority of participants with anorexia nervosa report using psychotropic medications despite lack of data supporting their efficacy. These data are concerning given the known adverse effects of these medications.
Authors: D B Allison; J L Mentore; M Heo; L P Chandler; J C Cappelleri; M C Infante; P J Weiden Journal: Am J Psychiatry Date: 1999-11 Impact factor: 18.112
Authors: J Brent Richards; Alexandra Papaioannou; Jonathan D Adachi; Lawrence Joseph; Heather E Whitson; Jerilynn C Prior; David Goltzman Journal: Arch Intern Med Date: 2007-01-22
Authors: David Mischoulon; Kamryn T Eddy; Aparna Keshaviah; Diana Dinescu; Stephanie L Ross; Andrea E Kass; Debra L Franko; David B Herzog Journal: J Affect Disord Date: 2010-11-24 Impact factor: 4.839
Authors: Peter T Katzmarzyk; Tiago V Barreira; Deirdre M Harrington; Amanda E Staiano; Steven B Heymsfield; Jeffrey M Gimble Journal: Bone Date: 2011-04-28 Impact factor: 4.398
Authors: Gijsbertus Ziere; Jeanne P Dieleman; Tischa J M van der Cammen; Albert Hofman; Huibert A P Pols; Bruno H Ch Stricker Journal: J Clin Psychopharmacol Date: 2008-08 Impact factor: 3.153
Authors: Elizabeth M Haney; Benjamin K S Chan; Susan J Diem; Kristine E Ensrud; Jane A Cauley; Elizabeth Barrett-Connor; Eric Orwoll; M Michael Bliziotes Journal: Arch Intern Med Date: 2007-06-25
Authors: Susan J Diem; Terri L Blackwell; Katie L Stone; Kristine Yaffe; Elizabeth M Haney; Michael M Bliziotes; Kristine E Ensrud Journal: Arch Intern Med Date: 2007-06-25
Authors: David M Garner; Michael L Anderson; Christopher D Keiper; Rachel Whynott; Lisa Parker Journal: Eat Weight Disord Date: 2016-02-01 Impact factor: 4.652
Authors: Stephanie Knatz; Christina E Wierenga; Stuart B Murray; Laura Hill; Walter H Kaye Journal: Dialogues Clin Neurosci Date: 2015-06 Impact factor: 5.986